Refine
Year of publication
Document Type
- Preprint (729)
- Article (504)
- Bachelor Thesis (1)
- Book (1)
- Part of a Book (1)
- Conference Proceeding (1)
- Doctoral Thesis (1)
Has Fulltext
- yes (1238)
Is part of the Bibliography
- no (1238)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (14)
- Hadron-Hadron scattering (experiments) (11)
- LHC (10)
- Heavy-ion collision (6)
- Jets (6)
- ALICE experiment (4)
- Collective Flow (4)
- Heavy Ions (4)
- Heavy Quark Production (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- ACL (2)
- Beauty production (2)
- COVID-19 (2)
- Cancer genomics (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Germany (2)
- Heavy-ion collisions (2)
- Lehre (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Monte Carlo (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Quality of life (2)
- Quark Gluon Plasma (2)
- Quarkonium (2)
- Rehabilitation (2)
- Relativistic heavy-ion collisions (2)
- SARS-CoV-2 (2)
- Shell model (2)
- Single electrons (2)
- Systematic Uncertainty (2)
- Time Projection Chamber (2)
- 900 GeV (1)
- ALICE LHC (1)
- ALICE detector (1)
- ARDS (1)
- Adaptive control (1)
- Advanced biliary tract cancer (1)
- Africa (1)
- Afrika (1)
- Allogeneic hematopoietic stem cell transplantation (1)
- Analysis and statistical methods (1)
- Anti-nuclei (1)
- Atherosclerosis (1)
- Automatic (1)
- Azacitidine (1)
- BRAF inhibitors (1)
- BTC (1)
- Back pain (1)
- Balance function (1)
- Bevorratung (1)
- Biodiversity (1)
- Boosted Jets (1)
- COVID (1)
- Calorimeters (1)
- Cancer (1)
- Cancer genetics (1)
- Canopy height model (1)
- Cardiac output (1)
- Cardiovascular diseases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge correlations (1)
- Charge fluctuations (1)
- Charged-particle density (1)
- Chemical company (1)
- Coase Theorem (1)
- Collective Flow, (1)
- Compact astrophysical objects (1)
- Comparison with QCD (1)
- Computational geometry (1)
- Conservative treatment (1)
- Costs (1)
- Covid-19 (1)
- Critical care (1)
- Cross-sectional study (1)
- DLI (1)
- Data processing methods (1)
- Decitabine (1)
- Depression (1)
- Direct reactions (1)
- Disabling back pain (1)
- ETS (1)
- Echocardiography (1)
- Ecosystem services (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Epidural abscess (1)
- Epilepsy (1)
- Exercise (1)
- Experimental models of disease (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- First-line regimen (1)
- Forschung (1)
- Frankfurt <Main> / Universität (1)
- Function (1)
- Functional outcome (1)
- GVHD (1)
- Galaxies and clusters (1)
- Genetics (1)
- Genome-wide association studies (1)
- Genomic instability (1)
- Guidelines (1)
- HBT (1)
- HIV (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Health information (1)
- Health risk analysis (1)
- Health-seeking behaviour (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion detectors (1)
- Helpline (1)
- Hemodynamic management (1)
- Hif1α (1)
- High-energy astrophysics (1)
- High-energy neutron detection (1)
- Hochschuldidaktik (1)
- Human well-being (1)
- Hypomethylating agents (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Italy (1)
- Jet Physics (1)
- Jet Substructure (1)
- Joint Ownership (1)
- Kompetenzen (1)
- Large Hadron Collider (1)
- Large detector systems for particle and astroparticle physics (1)
- Lehrqualifikation (1)
- Line reconstruction (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- Material budget (1)
- Mediation (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular medicine (1)
- Motor control (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multinomial logistic regression (1)
- Myocardial infarction (1)
- NK cell (1)
- NK cell subset (1)
- Nature (1)
- Neural network (1)
- Noisy point clouds (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- ORL (1)
- Occupational medicine (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Outcome (1)
- PDGFRβ (1)
- PM (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Performance of High Energy Physics Detectors (1)
- Personal- und Organisationsentwicklung (1)
- Pharmacodynamics (1)
- Physiotherapy (1)
- Plastic scintillator array (1)
- Post treatment (1)
- Prevalence (1)
- Prevention (1)
- Production Cross Section (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Property rights (1)
- Proton–proton (1)
- Public health (1)
- Pulse contour analysis (1)
- Pulse pressure variation (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quasi-free scattering (1)
- RTS (1)
- Rapidity Range (1)
- Rare diseases (1)
- Re-injury (1)
- Reactions with relativistic radioactive beams (1)
- Recurrence (1)
- Relapse (1)
- Relational contracts (1)
- Relativistic heavy ion physics (1)
- Renegotiation (1)
- Research (1)
- Residency (1)
- Resolution Parameter (1)
- Return to play (1)
- Return to sports (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCT (1)
- Secondary prevention (1)
- Seizure (1)
- Single muons (1)
- Single-leg hop for distance (1)
- Sorafenib (1)
- Specialist training (1)
- Spectroscopic factors (1)
- Spectroscopic factors & electromagnetic moments (1)
- Stroke (1)
- Stroke volume variation (1)
- Studienstiftung des Deutschen Volkes (1)
- Surgery (1)
- Sweden (1)
- TR (1)
- Target validation (1)
- Teaching (1)
- Telemedicine (1)
- Therapy (1)
- Thermodilution (1)
- Thrombosis (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse Momentum (1)
- Transverse momentum (1)
- Treatment modification (1)
- Treatment protocol (1)
- Trigger (1)
- UAV (1)
- University hospitals (1)
- Universitätskliniken (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Validity (1)
- Vector Boson Production (1)
- Venetoclax (1)
- Viral infection (1)
- Vorratsschutz (1)
- Weiterbildung (1)
- Wide rapidity coverage (1)
- Xenon-based gas mixture (1)
- accident (1)
- acupuncture (1)
- biological control (1)
- biologische Bekämpfung (1)
- birds (1)
- c-kit (1)
- cART (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- cigarillos (1)
- climate change (1)
- climatic niche (1)
- concurrent (1)
- dE/dx (1)
- decompressive craniectomy (1)
- detector (1)
- dietary niche (1)
- dispersal (1)
- drone (1)
- exercise therapy (1)
- experimental results (1)
- faculty development (1)
- fine spatial resolution remote sensing (1)
- frugivory (1)
- functional traits (1)
- habitat niche (1)
- heavy ion experiments (1)
- higher education pedagogy (1)
- immune reconstitution (1)
- injury (1)
- intracerebral hemorrhage (ICH) (1)
- lockdown (1)
- medical training (1)
- metastasis-directed radiotherapy (1)
- mountain (1)
- organizational development (1)
- particulate matter (1)
- pediatric intensive care (1)
- plant height (1)
- quark gluon plasma (1)
- spectra (1)
- stereotactic (1)
- stored grain (1)
- stored product protection (1)
- structure-from-motion photogrammetry (1)
- targeted therapy (1)
- teach-the-teacher (1)
- teaching competencies (1)
- teaching skills (1)
- tension type headache (1)
- tobacco smoke (1)
- traditional Chinese medicine (1)
- trauma (1)
- tyrosine kinase inhibitors (1)
- vaccination (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- vulnerability (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1183)
- Frankfurt Institute for Advanced Studies (FIAS) (1059)
- Informatik (1024)
- Medizin (34)
- Biowissenschaften (5)
- ELEMENTS (5)
- Senckenbergische Naturforschende Gesellschaft (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Geowissenschaften (3)
- Informatik und Mathematik (3)
Burkitt lymphoma (BL) is the most common B-cell lymphoma in children. Within the International Cancer Genome Consortium (ICGC), we performed whole genome and transcriptome sequencing of 39 sporadic BL. Here, we unravel interaction of structural, mutational, and transcriptional changes, which contribute to MYC oncogene dysregulation together with the pathognomonic IG-MYC translocation. Moreover, by mapping IGH translocation breakpoints, we provide evidence that the precursor of at least a subset of BL is a B-cell poised to express IGHA. We describe the landscape of mutations, structural variants, and mutational processes, and identified a series of driver genes in the pathogenesis of BL, which can be targeted by various mechanisms, including IG-non MYC translocations, germline and somatic mutations, fusion transcripts, and alternative splicing.
Introduction: Dravet syndrome (DS) is a rare developmental and epileptic encephalopathy. This study estimated cost, cost-driving factors and quality of life (QoL) in patients with Dravet syndrome and their caregivers in a prospective, multicenter study in Germany.
Methods: A validated 3–12-month retrospective questionnaire and a prospective 3-month diary assessing clinical characteristics, QoL, and direct, indirect and out-of-pocket (OOP) costs were administered to caregivers of patients with DS throughout Germany.
Results: Caregivers of 93 patients (mean age 10.1 years, ±7.1, range 15 months–33.7 years) submitted questionnaires and 77 prospective diaries. The majority of patients (95%) experienced at least one seizure during the previous 12 months and 77% a status epilepticus (SE) at least once in their lives. Over 70% of patients had behavioural problems and delayed speech development and over 80% attention deficit symptoms and disturbance of motor skills and movement coordination. Patient QoL was lower than in the general population and 45% of caregivers had some form of depressive symptoms. Direct health care costs per three months were a mean of €6,043 ± €5,825 (median €4054, CI €4935-€7350) per patient. Inpatient costs formed the single most important cost category (28%, €1,702 ± €4,315), followed by care grade benefits (19%, €1,130 ± €805), anti-epileptic drug (AED) costs (15%, €892 ± €1,017) and ancillary treatments (9%, €559 ± €503). Total indirect costs were €4,399 ±€ 4,989 (median €0, CI €3466-€5551) in mothers and €391 ± €1,352 (median €0, CI €195-€841) in fathers. In univariate analysis seizure frequency, experience of SE, nursing care level and severe additional symptoms were found to be associated with total direct healthcare costs. Severe additional symptoms was the single independently significant explanatory factor in a multivariate analysis.
Conclusions: This study over a period up to 15 months revealed substantial direct and indirect healthcare costs of DS in Germany and highlights the relatively low patient and caregiver QoL compared with the general population.
Supermassive black hole binaries (SMBHBs) are among the most powerful known sources of gravitational waves (GWs). Accordingly, these systems could dominate the stochastic gravitational wave background (GWB) in the micro- and millihertz frequency range. The time until the merger of two SMBHs in the nucleus of a galaxy can be shortened through dynamical friction due to the presence of dark matter (DM) spikes around the SMBHs. To calculate the orbital evolution of individual SMBHBs within the Newtonian approximation, the SMBHBpy code is developed. This work confirms that the GW signals from SMBHBs with DM spikes can be clearly distinguished from those without any matter. Making use of the upper limit on the characteristic strain of the GWB derived from the data of the Cassini spacecraft mission in 2001/2002, a lower limit on the matter density around SMBHBs is derived in this study. The result is subsequently compared with the theoretical density profiles for cold dark matter and self-interacting dark matter spikes.
Background: Intensive Care Resources are heavily utilized during the COVID-19 pandemic. However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon ICU admission remain inadequate. This study aimed to develop a machine learning model, based on retrospective & prospective clinical data, to stratify patient risk and predict ICU survival and outcomes. Methods: A Germany-wide electronic registry was established to pseudonymously collect admission, therapeutic and discharge information of SARS-CoV-2 ICU patients retrospectively and prospectively. Machine learning approaches were evaluated for the accuracy and interpretability of predictions. The Explainable Boosting Machine approach was selected as the most suitable method. Individual, non-linear shape functions for predictive parameters and parameter interactions are reported. Results: 1039 patients were included in the Explainable Boosting Machine model, 596 patients retrospectively collected, and 443 patients prospectively collected. The model for prediction of general ICU outcome was shown to be more reliable to predict “survival”. Age, inflammatory and thrombotic activity, and severity of ARDS at ICU admission were shown to be predictive of ICU survival. Patients’ age, pulmonary dysfunction and transfer from an external institution were predictors for ECMO therapy. The interaction of patient age with D-dimer levels on admission and creatinine levels with SOFA score without GCS were predictors for renal replacement therapy. Conclusions: Using Explainable Boosting Machine analysis, we confirmed and weighed previously reported and identified novel predictors for outcome in critically ill COVID-19 patients. Using this strategy, predictive modeling of COVID-19 ICU patient outcomes can be performed overcoming the limitations of linear regression models. Trial registration “ClinicalTrials” (clinicaltrials.gov) under NCT04455451.
Hintergrund: Ab Frühjahr 2020 kam es zur weltweiten Verbreitung von SARS-CoV‑2 mit der heute als erste Welle der Pandemie bezeichneten Phase ab März 2020. Diese resultierte an vielen Kliniken in Umstrukturierungen und Ressourcenverschiebungen. Ziel unserer Arbeit war die Erfassung der Auswirkungen der Pandemie auf die universitäre Hals-Nasen-Ohren(HNO)-Heilkunde für die Forschung, Lehre und Weiterbildung. Material und Methoden: Die Direktorinnen und Direktoren der 39 Universitäts-HNO-Kliniken in Deutschland wurden mithilfe einer strukturierten Online-Befragung zu den Auswirkungen der Pandemie im Zeitraum von März bis April 2020 auf die Forschung, Lehre und die Weiterbildung befragt. Ergebnisse: Alle 39 Direktorinnen und Direktoren beteiligten sich an der Umfrage. Hiervon gaben 74,4 % (29/39) an, dass es zu einer Verschlechterung ihrer Forschungstätigkeit infolge der Pandemie gekommen sei. Von 61,5 % (24/39) wurde berichtet, dass pandemiebezogene Forschungsaspekte aufgegriffen wurden. Von allen Kliniken wurde eine Einschränkung der Präsenzlehre berichtet und 97,5 % (38/39) führten neue digitale Lehrformate ein. Im Beobachtungszeitraum sahen 74,4 % der Klinikdirektoren die Weiterbildung der Assistenten nicht gefährdet. Schlussfolgerung: Die Ergebnisse geben einen Einblick in die heterogenen Auswirkungen der Pandemie. Die kurzfristige Bearbeitung pandemiebezogener Forschungsthemen und die Einführung innovativer digitaler Konzepte für die studentische Lehre belegt eindrücklich das große innovative Potenzial und die schnelle Reaktionsfähigkeit der HNO-Universitätskliniken, um auch während der Pandemie ihre Aufgaben in der Forschung, Lehre und Weiterbildung bestmöglich zu erfüllen.
Objective: Combination antiretroviral therapy (cART) has markedly increased survival and quality of life in people living with HIV. With the advent of new treatment options, including single-tablet regimens, durability and efficacy of first-line cART regimens are evolving.
Methods: We analyzed data from the prospective multicenter German Clinical Surveillance of HIV Disease (ClinSurv) cohort of the Robert-Koch Institute. Kaplan–Meier and Cox proportional hazards models were run to examine the factors associated with treatment modification. Recovery after treatment initiation was analyzed comparing pre-cART viral load and CD4+ T-cell counts with follow-up data.
Results: We included 8788 patients who initiated cART between 2005 and 2017. The sample population was predominantly male (n = 7040; 80.1%), of whom 4470 (63.5%) were reporting sex with men as the transmission risk factor. Overall, 4210 (47.9%) patients modified their first-line cART after a median time of 63 months (IQR 59–66). Regimens containing integrase strand transfer inhibitors (INSTI) were associated with significantly lower rates of treatment modification (adjusted hazard ratio 0.44; 95% CI 0.39–0.50) compared to protease inhibitor (PI)-based regimens. We found a decreased durability of first-line cART significantly associated with being female, a low CD4+ T-cell count, cART initiation in the later period (2011–2017), being on a multi-tablet regimen (MTR).
Conclusions: Drug class and MTRs are significantly associated with treatment modification. INSTI-based regimens showed to be superior compared to PI-based regimens in terms of durability.
Correction to: Infection (2020) 48:723–733 https://doi.org/10.1007/s15010-020-01469-6. The original version of this article unfortunately contained a mistake. In this article the authors Dirk Schürmann at affiliation Charité, University Medicine, Berlin, Olaf Degen at affiliation University Clinic Hamburg Eppendorf, Hamburg and Heinz-August Horst at affiliation University Hospital Schleswig–Holstein, Kiel, Germany were missing from the author list. The original article has been corrected.
Results are presented on event-by-event fluctuations in transverse momentum of charged particles, produced at forward rapidities in p+p, C+C, Si+Si and Pb+Pb collisions at 158 AGeV. Three different characteristics are discussed: the average transverse momentum of the event, the Phi_pT fluctuation measure and two-particle transverse momentum correlations. In the kinematic region explored, the dynamical fluctuations are found to be small. However, a significant system size dependence of Phi_pT is observed, with the largest value measured in peripheral Pb+Pb interactions. The data are compared with predictions of several models. PACS numbers: 14.20.Jn, 13.75.Cs, 12.39.-x
A non-monotonic energy dependence of the K + / pi + ratio with a sharp maximum close to 30 A GeV is observed in central Pb+Pb collisions. Within a statistical model of the early stage, this is interpreted as a sign of the phase transition to a QGP, which causes a sharp change in the energy dependence of the strangeness to entropy ratio. This observation naturally motivates us to study the production of multistrange hyperons (Xi, Omega) as a function of the beam energy. Furthermore it was suggested that the kinematic freeze-out of Omega takes place directly at QGP hadronization. If this is indeed the case, the transverse momentum spectra of the Omega directly reflect the transverse expansion velocity of a hadronizing QGP. In this report we show preliminary NA49 results on Omega - and Omega + production in central Pb+Pb collisions at 40 and 158 A GeV and compare them to measurements of Xi - and Xi + production in central Pb+Pb collisions at 30, 40, 80 and 158 A GeV.
The bile acid activated transcription factor farnesoid X receptor (FXR) regulates numerous metabolic processes and is a rising target for the treatment of hepatic and metabolic disorders. FXR agonists have revealed efficacy in treating non-alcoholic steatohepatitis (NASH), diabetes and dyslipidemia. Here we characterize imatinib as first-in-class allosteric FXR modulator and report the development of an optimized descendant that markedly promotes agonist induced FXR activation in a reporter gene assay and FXR target gene expression in HepG2 cells. Differential effects of imatinib on agonist-induced bile salt export protein and small heterodimer partner expression suggest that allosteric FXR modulation could open a new avenue to gene-selective FXR modulators.